This lecture gives you a systematic clinical overview of the upcoming DEWS III recommendations for dry eye disease, highlighting the most important updates and changes compared with DEWS II.

You’ll learn how new evidence and evolving clinical understanding may influence diagnosis, classification, patient assessment, and treatment strategies in everyday practice. Clinical case presentations are be included to illustrate how these recommendations can be applied in real-world settings.

This session took place at Clinical Conference in Norway on 22 September 2026 and was organised by Ursapharm.